Avoro Capital Advisors LLC - 30 Sep 2025 SCHEDULE 13G/A Report for MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share
Symbol
MLTX
Shares outstanding
63,492,063 shares
Disclosed Ownership
2,000,000 shares
Ownership
3.2%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 09:03:05 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Quoteable Key Fact

"Avoro Capital Advisors LLC disclosed 3.2% ownership in MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX) on 30 Sep 2025."

Quick Takeaways

  • Avoro Capital Advisors LLC filed SCHEDULE 13G/A for MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX).
  • Disclosed ownership: 3.2%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 14 Nov 2025, 09:03.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 3.2% 2,000,000 2,000,000 0 /s/ Scott Epstein Scott Epstein, Chief Operating Officer & Chief Compliance Officer
Behzad Aghazadeh 3.2% 2,000,000 2,000,000 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually